Apyx Medical Corporation Common Stock (APYX)

About APYX

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue du…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

205

Website

apyxmedical.com/

Fundamentals

1-day range

$3$3.22

Market cap

$175.19M

P/E (trailing)

—

P/E (forward)

-11.94

EPS (trailing)

$-0.22

Dividend yield

—

Beta

1.47

Avg. volume

133.2K

Forecasts

5 analyst ratings

Apyx Medical Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• APYX

  Apyx Medical Corporation Common Stock

  $3.08

  ▲ 2.67%
  Market cap $175.19MP/E —
  $1.7$5.08
• LUCD

  Lucid Diagnostics Inc. Common Stock

  $0.9989

  ▲ 1.51%
  Market cap $196.65MP/E —
  $0.8605$1.63
• PDEX

  Pro-Dex Inc. Common Stock

  $62.37

  ▼ 3.85%
  Market cap $203.09MP/E 17.93
  $23.47$69.86
• MBOT

  Microbot Medical Inc. Common Stock

  $1.48

  ▼ 1.67%
  Market cap $118.88MP/E —
  $1.44$4.67
• GUTS

  Fractyl Health Inc. Common Stock

  $0.6485

  ▼ 12.60%
  Market cap $107.44MP/E —
  $0.377$2.45
• LNSR

  LENSAR Inc. Common Stock

  $8.3

  ▼ 1.89%
  Market cap $66.07MP/E 3.44
  $4.95$12.94
• NYXH

  Nyxoah SA Ordinary Shares

  $1.6

  ▲ 1.59%
  Market cap $63.75MP/E —
  $1.14$6.36

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  Benzinga · 8/12/2026
• Apyx Medical Corporation (APYX) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/7/2026
• Apyx Medical (NASDAQ:APYX) Shares Dip Despite Q2 Earnings Beat
  ChartMill · 8/6/2026
• Apyx Medical Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $13.884M Beat $13.175M Estimate
  Benzinga · 8/6/2026
• Apyx Medical Affirms FY2026 Sales Guidance of $59.000M-$60.000M vs $59.554M Est
  Benzinga · 8/6/2026

• Lawrence Waldman · June 30, 2026 · Option Exercise

  12.0K @ $1.88
• Lawrence Waldman · June 30, 2026 · Tax Withholding

  5.0K @ $4.49
• Shawn David Roman · June 11, 2026 · Grant

  88.0K
• Levine Wendy Lauren · June 11, 2026 · Grant

  50.0K
• Minnie Baylor-Henry · June 11, 2026 · Grant

  50.0K
• Goodwin Charles D. II · June 11, 2026 · Grant

  213.9K
• Stavros G. Vizirgianakis · June 11, 2026 · Grant

  450.0K
• Lawrence Waldman · June 11, 2026 · Grant

  50.0K
• Moshe Citronowicz · June 11, 2026 · Grant

  63.4K
• Matthew C. Hill · June 11, 2026 · Grant

  132.1K
• Moshe Citronowicz · March 15, 2026 · Option Exercise

  37.0K @ $1.8

Institutional Ownership

March 31, 2026

Total shares held

20.40M

Total value held

$74.91M

Institutional holders

64